The Federation of Medical & Sales Representatives Association of India, or FMRAI, has moved the Supreme Court with a petition. It wants the apex court to direct the Centre to formulate a Uniform Code of Pharmaceutical Marketing Practices to curb alleged unethical practices of pharma companies. The NGO, which had moved the court in March, wants an effective monitoring mechanism, transparency, accountability and consequences for violations of the code.Now, during the course of the hearing, the petitioner has accused the makers of Dolo-650 of bribing doctors with freebies worth 1,000 crore rupees to recommend the pills. On its part, Micro Labs Ltd, which makes the drug, has denied the allegations as baseless. About a month ago, the income tax department had conducted raids at the drug maker’s offices for alleged tax evasion.Another petition, which had reached the Supreme Court recently, had claimed that pharma companies were giving freebies such as